We are live on ! Find out more
ONCS

OncoSec Medical Incorporated
ONCS

Delisted

ONCS was delisted on the 23rd of June, 2023.

Back to rankings

25 hedge funds and large institutions have $3.86M invested in OncoSec Medical Incorporated in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% less funds holding

Funds holding: 28 → 25 (-3)

37% less capital invested

Capital invested by funds: $6.09M → $3.86M (-$2.23M)

50% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 8

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
25
Holders Change
-3
Holders Change %
-10.71%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
8
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$20.9K
2
Citadel Advisors
Citadel Advisors
Florida
+$20.6K
3
VVP
Venture Visionary Partners
Ohio
+$1.3K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$671
5
Wells Fargo
Wells Fargo
California
+$19

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$43.7K
2
DADC
D.A. Davidson & Co
Montana
-$31.8K
3
VF
Virtu Financial
New York
-$18K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$15.5K
5
UBS Group
UBS Group
Switzerland
-$9K
Name Holding Trade Value Shares
Change 		Change in
Stake
APM
1
Avidity Partners Management
Texas
$2.19M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$543K – – –
Bank of New York Mellon
3
Bank of New York Mellon
New York
$285K -$2.26K -118 -0.7%
SM
4
Salzhauer Michael
$220K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$201K +$671 +35 +0.3%
TAM
6
Tocqueville Asset Management
New York
$55K -$882 -46 -1%
Renaissance Technologies
7
Renaissance Technologies
New York
$54K +$20.9K +1,087 +49%
LFCM
8
Long Focus Capital Management
Puerto Rico
$51K – – –
Citadel Advisors
9
Citadel Advisors
Florida
$39K +$20.6K +1,074 +81%
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$36K -$15.5K -806 -27%
BlackRock
11
BlackRock
New York
$33K -$43.7K -2,277 -53%
State Street
12
State Street
Massachusetts
$32K – – –
Northern Trust
13
Northern Trust
Illinois
$30K – – –
RC
14
RegentAtlantic Capital
New Jersey
$26K – – –
SFP
15
Sandbox Financial Partners
Maryland
$19K -$2.19K -114 -9%
SSA
16
Schonfeld Strategic Advisors
New York
$17K – – –
DADC
17
D.A. Davidson & Co
Montana
$12K -$31.8K -1,659 -70%
MSAM
18
Moloney Securities Asset Management
Missouri
$9K – – –
Group One Trading
19
Group One Trading
Illinois
$5K -$173 -9 -3%
TRCT
20
Tower Research Capital (TRC)
New York
$4K -$2.78K -145 -37%
Bank of America
21
Bank of America
North Carolina
$2K – – –
VVP
22
Venture Visionary Partners
Ohio
$1.11K +$1.3K +68 New
Morgan Stanley
23
Morgan Stanley
New York
$1K – – –
VF
24
Virtu Financial
New York
– -$18K -699 Closed
UBS Group
25
UBS Group
Switzerland
– -$9K -372 Closed
1
2

ONCS Hedge Fund Activity: Q2 2022 in Review

25 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q2 2022, worth a combined $3.86M — down 37% from $6.09M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of ONCS and 1 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 4 added.

The largest buyer was Renaissance Technologies, adding an estimated $20.9K. The largest seller was BlackRock, cutting an estimated $43.7K.

  • 25 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q2 2022, down from 28 in Q1 2022.
  • Funds reported $3.86M of OncoSec Medical Incorporated stock for Q2 2022, down 37% quarter-over-quarter.
  • 1 fund opened new OncoSec Medical Incorporated positions in Q2 2022 and 4 closed out, a net change of -3 holders.
  • The largest OncoSec Medical Incorporated buyer in Q2 2022 was Renaissance Technologies, an estimated $20.9K added.
  • The largest OncoSec Medical Incorporated seller in Q2 2022 was BlackRock, an estimated $43.7K sold.

Based on aggregated 13F filings for Q2 2022.